Nothing about sarcoidosis is easy. First identified in 1877, it is quite common. In the United States, lifetime risk is 2.4% and 0.85% for African American persons and White persons, respectively.

Please provide your email address to receive an email when new articles are posted on . Patients treated with the JAK inhibitor tofacitinib saw a dose-dependent response in the treatment of cutaneous ...

Dr. Gilotra and Dr. Lin were each awarded $100k through FSR’s Cardiac Sarcoidosis Grant program, and Dr. Kahlmann and Dr.

Sarcoidosis is a multi-systemic disease of unknown etiology with a clinical presentation ranging from asymptomatic disease to organ failure. While some patients with sarcoidosis have spontaneous ...

Please provide your email address to receive an email when new articles are posted on . In a retrospective cohort study, Marc A. Judson, MD, professor of medicine and chief of pulmonary and critical ...

NEW YORK & BASEL, Switzerland--(BUSINESS WIRE)--Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare autoimmune and inflammatory diseases, today announced ...

– Retrospective analysis suggests Acthar Gel treatment was associated with similar improvement in health status and overall symptom reduction in African Americans and non-African Americans with ...

Task force members from the European Respiratory Society evaluated available evidence for treatment of various manifestations of sarcoidosis but said their recommendations were not the last word. As ...

(RTTNews) - aTyr Pharma, Inc. (ATYR), a clinical-stage biotechnology company, on Wednesday announced that it will present three important posters on efzofitimod at the American Thoracic Society or ATS ...

DUBLIN, July 1, 2021 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced new treatment guidelines for sarcoidosis from the European Respiratory ...

We read with interest the Position Paper by Athol U Wells and colleagues concerning the paradigm shift in corticosteroid therapy for sarcoidosis.1 The search for specific targets, such as those ...